GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
B

Biotron BIT.AX · AUD

Health Care · ASX · 🇦🇺 Australia

Compare

0.00

—

Close of 9 Nov 2026, in AUD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

Price performance

Chart by TradingView, with its own licensed prices

Biotron — daily ASX:BIT

No embeddable chart for this listing. TradingView's free widgets do not cover this exchange, and an unsupported symbol would render an error panel rather than a chart.

View Biotron on TradingView ↗
Market value
A$2.0m
Last close × shares
Volume
2m
Shares, 9 Nov 2026

About Biotron

Its shares trade on ASX under the ticker BIT.AX. It has been listed since 24 January 2001. In the fiscal year to 30 June 2025, it reported revenue of A$1.8m and a net loss of A$318,572. At that date it held total assets of A$980,401 and shareholders' equity of A$551,895.

Biotron Ltd. is a clinical stage Australian biotechnology company. The company is headquartered in North Ryde, New South Wales. The company went IPO on 2001-01-24. The firm is engaged in the funding and management of intermediate, and applied biotechnology research and development projects. The firm is focused on the ongoing clinical development of its antiviral platform. The firm's lead antiviral drug, BIT225 is in mid-stage clinical development with approximately eight clinical trials completed. The firm has conducted clinical trails in human immunodeficiency virus-1 (HIV-1), hepatitis C virus (HCV) and HIV-1/HCV co-infected population. The clinical trials showed that BIT225 targets and reduces levels of HIV-1 residing in long-lived monocyte/macrophage reservoirs. BIT225 has clinical antiviral activity against both HIV-1 and HCV. BIT225 is pan-genotypic and is active against all HCV genotypes, including GT3. The firm designs and develops drugs that target a class of virus protein known as viroporins. Its earlier stage programs include Dengue, Influenza and others.

Figures and description from our data supplier, not checked against the company's own report.

More about Biotron →

Latest on Biotron

Our reporting

We have not reported on Biotron yet.

Other Health Care listings

Scenario calculator

Try your own numbers. This is arithmetic, not a forecast.

Interactive

Gain or loss

—

Return

—

Leaves out fees, taxes and financing.

Frequently asked questions

What is Biotron's ticker?

Biotron trades as BIT.AX on ASX, under ISIN AU000000BIT4.

What was Biotron's last closing price?

0.00 on 9 Nov 2026. The figure is in AUD and is never converted.

Sources and methodology

Chart
TradingView
Close and company data
Our data supplier
News
Our reporting

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.